About
Allan Brasier, MD, ICTR Executive Director, is also Senior Associate Dean in the School of Medicine and Public Health (SMPH).
Dr. Brasier joined UW ICTR in 2018. He received his MD degree from the University of California, San Francisco, a clinical and research fellowship in Adult Endocrinology at Massachusetts General Hospital, and is dually boarded in Internal Medicine and Endocrinology/Metabolism. He was founding Director of the Institute for Translational Science at the University of Texas Medical Branch, where he developed systematic approaches for the advancing translational research. This work in Translational Teams is now being applied and advanced at ICTR and has led to development of approaches to enhance reproducibility in science and skills-based training in research leadership.
In addition to his contributions to Translational Teamwork, Dr. Brasier is internationally recognized for his original and high-impact research on mechanisms of innate inflammation and its role in advancing pulmonary and cardiovascular disease. His pioneering work applies systems-level bioinformatics to integrate information from high-throughput studies to generate novel mechanistic insights about innate inflammation and its central role in organ fibrosis. These studies inform translational research programs in viral induced inflammation, airway remodeling, and inflammatory bowel disease.
In advancing the ICTR strategic plan, Dr. Brasier is responsible for working with partners at the Marshfield Clinic and six UW schools and colleges (the Schools of Medicine & Public Health, Education, Nursing, Pharmacy, and Veterinary Medicine, and the College of Engineering) to expand university and academic partnerships.
He spearheads the Precision Medicine Strategic Alliance Program in partnership with the SMPH Human Proteomics Program, and leads development of the Leadership and Skills Enhancement for Research (LASER) training program.